Hepatectomy for hepatocellular carcinoma in stage B and C of BCLC classification: A feasible, safe, and effective treatment

被引:0
|
作者
Torzilli, G. [1 ]
Donadon, M. [1 ]
Marconi, M. [1 ]
Del Fabbro, D. [1 ]
Palinisano, A. [1 ]
Spinelli, A. [1 ]
Bianchi, P. [1 ]
Montorsi, M. [1 ]
机构
[1] Univ Milan, IRCCS, Ist Clin Humanitas, Dept Surg 3,Liver Surg Hamanitas, Milan, Italy
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:5 / 5
页数:1
相关论文
共 50 条
  • [21] Optimizing the management of patients with BCLC stage-B hepatocellular carcinoma: Modern surgical resection as a feasible alternative to transarterial chemoemolization
    Ciria, R.
    Lopez-Cillero, P.
    Gallardo, A. -B.
    Cabrera, J.
    Pleguezuelo, M.
    Ayllon, M. -D.
    Luque, A.
    Zurera, L.
    Espejo, J. -J.
    Rodriguez-Peralvarez, M.
    Montero, J. -L.
    de la Mata, M.
    Briceno, J.
    EJSO, 2015, 41 (09): : 1153 - 1161
  • [22] COMPARISON OF TREATMENT OUTCOME BETWEEN LIVING DONOR LIVER TRANSPLANTATION AND SORAFENIB FOR PATIENTS WITH BCLC B OR C STAGE HEPATOCELLULAR CARCINOMA
    Cho, Y.
    Lee, J-H
    Lee, D. H.
    Cho, E. J.
    Yu, S. J.
    Yi, N-J
    Lee, K-W
    Suh, K-S
    Kim, Y. J.
    Yoon, J-H
    JOURNAL OF HEPATOLOGY, 2016, 64 : S553 - S554
  • [23] Prognosis After Resection of Barcelona Clinic Liver Cancer (BCLC) Stage 0, A, and B Hepatocellular Carcinoma: A Comprehensive Assessment of the Current BCLC Classification
    Diamantis I. Tsilimigras
    Fabio Bagante
    Kota Sahara
    Dimitrios Moris
    J. Madison Hyer
    Lu Wu
    Francesca Ratti
    Hugo P. Marques
    Olivier Soubrane
    Anghela Z. Paredes
    Vincent Lam
    George A. Poultsides
    Irinel Popescu
    Sorin Alexandrescu
    Guillaume Martel
    Aklile Workneh
    Alfredo Guglielmi
    Tom Hugh
    Luca Aldrighetti
    Itaru Endo
    Timothy M. Pawlik
    Annals of Surgical Oncology, 2019, 26 : 3693 - 3700
  • [24] Prognosis After Resection of Barcelona Clinic Liver Cancer (BCLC) Stage 0, A, and B Hepatocellular Carcinoma: A Comprehensive Assessment of the Current BCLC Classification
    Tsilimigras, Diamantis, I
    Bagante, Fabio
    Sahara, Kota
    Moris, Dimitrios
    Hyer, J. Madison
    Wu, Lu
    Ratti, Francesca
    Marques, Hugo P.
    Soubrane, Olivier
    Paredes, Anghela Z.
    Lam, Vincent
    Poultsides, George A.
    Popescu, Irinel
    Alexandrescu, Sorin
    Martel, Guillaume
    Workneh, Aklile
    Guglielmi, Alfredo
    Hugh, Tom
    Aldrighetti, Luca
    Endo, Itaru
    Pawlik, Timothy M.
    ANNALS OF SURGICAL ONCOLOGY, 2019, 26 (11) : 3693 - 3700
  • [25] The prognosis of single large hepatocellular carcinoma was distinct from the BCLC stage A or B
    Lee, P. -C.
    Su, C. -W.
    Fang, K. -C.
    Chang, C. -Y.
    Huang, Y. -H.
    Huo, T. -I.
    Hou, M. -C.
    Lin, H. -C.
    Wu, J. -C.
    JOURNAL OF HEPATOLOGY, 2017, 66 (01) : S618 - S619
  • [26] Comparison of the efficacy and safety of Transarterial chemoembolization with and without Apatinib for the treatment of BCLC stage C hepatocellular carcinoma
    Chen, Shiguang
    Yu, Wenchang
    Zhang, Kongzhi
    Liu, Weifu
    BMC CANCER, 2018, 18
  • [27] Comparison of the efficacy and safety of Transarterial chemoembolization with and without Apatinib for the treatment of BCLC stage C hepatocellular carcinoma
    Shiguang Chen
    Wenchang Yu
    Kongzhi Zhang
    Weifu Liu
    BMC Cancer, 18
  • [28] A NEW MODEL TO ESTIMATE SURVIVAL IN PATIENTS WITH HEPATOCELLULAR CARCINOMA IN BCLC B STAGE
    Ninomiya, Masashi Ninomiya
    Inoue, Jun
    Iwata, Tomoaki
    Sano, Akitoshi
    Tsuruoka, Mio
    Ueno, Yoshiyuki
    Masamune, Atsushi
    HEPATOLOGY, 2021, 74 : 613A - 614A
  • [29] Comparison of the efficacy and safety of transarterial chemoembolization with and without apatinib for the treatment of BCLC Stage C hepatocellular carcinoma
    Chen, S.
    EUROPEAN JOURNAL OF CANCER, 2018, 103 : E123 - E123
  • [30] A novel treatment strategy using indocyanine green for transarterial chemoembolization in BCLC stage C hepatocellular carcinoma
    Mei, Jie
    Li, Shao-Hua
    Wang, Qiao-Xuan
    Zhong, Xiao-Ping
    Lu, Liang-He
    Kan, Anna
    Wei, Wei
    Guo, Rong-Ping
    CANCER MEDICINE, 2020, 9 (01): : 62 - 76